New horizons in multimodality molecular imaging and novel radiotracers

TY - JOUR

T1 - New horizons in multimodality molecular imaging and novel radiotracers

AU - Barrington, Sally

AU - Blower, Philip

AU - Cook, Gary

N1 - © Royal College of Physicians 2017. All rights reserved.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes.

AB - Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes.

U2 - 10.7861/clinmedicine.17-5-444

DO - 10.7861/clinmedicine.17-5-444

M3 - Article

C2 - 28974596

SN - 1470-2118

VL - 17

SP - 444

EP - 448

JO - Clinical Medicine

JF - Clinical Medicine

IS - 5

ER -